Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of BK virus-associated haemorrhagic cystitis after allogeneic HSCT

0013282 2022 RIV CH eng J
Šťastná Marková, Markéta - Hamšíková, Eva - Hainz, Petr - Hubáček, P. - Kroutilová, Marie - Kryštofová, Jitka - Ludvíková, Viera - Musil, Jan - Pecherková, Pavla - Saláková, Martina - Šroller, Vojtěch - Vydra, Jan - Němečková, Šárka^G
Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk of BK virus-associated haemorrhagic cystitis after allogeneic HSCT.
Vaccines. Vol. 9, no. 11 (2021), art. no. 1226. ISSN 2076-393X
Grant: Ministerstvo zdravotnictví NV17-31593A
Institucionální podpora: RVO:00023736
Klíčová slova: human BK polyomavirus 1 and 4 (BKPyV 1 and 4) * haemorrhagic cystitis * anti/BKPyV IgG
Cite Score: 4.500, rok: 2021; SJR: 1.004, rok: 2021; IF: 4.961, rok: 2021
DOI: 10.3390/vaccines9111226